NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CellX Biosolutions

CellX Biosolutions

Private
ZurichEnergy & Sustainabilityhttps://www.cellx.ch/

Last Round

Pre Seed

Feb 25, 2025

Total Funding Raised

$1.88M

Company Overview

CellX Biosolutions is a biotechnology company that develops high-performance bacterial solutions to destroy persistent industrial pollutants like PFAS, offering a sustainable alternative to traditional incineration methods.

Sector

Energy & Sustainability

Verticals

Biotechnology, Waste Management, Water Treatment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

bioremediationPFAS degradationindustrial wastewater treatmentbacterial consortiaforever chemicalsmicrofluidicsenvironmental biotechnologypollutant biodegradationsoil remediationsynthetic biologymicroplastic degradationwaste managementgreen chemistryclean tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellX Biosolutions Comparables

Compare CellX Biosolutions with similar companies based on industry and business-model similarity.

CellX Biosolutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allied Microbiota
84%
Fixed Earth Innovations
83%
Novobiom
81%

CellX Biosolutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 25, 2025

Key People

Founding team and executive leadership

Geoffrey Besnier

COO & Co-Founder

Founding Team

Estelle Clerc

Founder and CEO

Founding Team

CellX Biosolutions Investors

Notable investors and investment history

CellX Biosolutions investors
InvestorRounds
Positron VenturesPre Seed
KickfundPre Seed
Venture KickPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 23, 2025

    Grew 50% QoQ from 6 to 9 employees.

CellX Biosolutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellX Biosolutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellX Biosolutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range13
Year Founded2024
Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.